Abstract
BK virus nephropathy (BKVN) is an opportunistic infection in the post-kidney transplantation period with a prevalence of up to 3–5% [1]. It can lead to allograft dysfunction, ureteral strictures, de novo DSA due to the reduction of immunosuppression, graft rejection, and rarely urological malignancies. The net state of immunosuppression is the most important risk factor for BKVN, and there is a higher risk with the use of anti-thymocyte globulin (ATG) and mycophenolate mofetil (MMF) or tacrolimus [2]. Prior allograft loss attributed to BKVN is not a contraindication for re-transplantation [3, 4]. We will explore some of the considerations in retransplantation amongst this patient population.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Myint TM, Chong CHY, Wyld M, Nankivell B, Kable K, Wong G. Polyoma BK virus in kidney transplant recipients: screening, monitoring, and management. Transplantation. 2022;106(1):e76–89.
Dharnidharka VR, Cherikh WS, Abbott KC. An OPTN analysis of national registry data on treatment of BK virus allograft nephropathy in the United States. Transplantation. 2009;87(7):1019–26.
Hirsch HH, Randhawa PS, AST Infectious diseases Community of Practice. BK polyomavirus in solid organ transplantation-guidelines from the American society of transplantation infectious diseases community of practice. Clin Transpl. 2019;33(9):e13528.
Nguyen K, Diamond A, Carlo AD, Karhadkar S. Characterization of kidney Retransplantation following graft failure due to BK virus nephropathy. J Surg Res. 2021;269:110–8.
Geetha D, Sozio SM, Ghanta M, et al. Results of repeat renal transplantation after graft loss from BK virus nephropathy. Transplantation. 2011;92(7):781–6.
Hirsch HH, Knowles W, Dickenmann M, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med. 2002;347(7):488–96.
Dong R, Shetty A, Tambur AR, Ison MG. Outcomes of repeat kidney transplantation following prior graft failure secondary to BK nephropathy: a single-center retrospective study. Transpl Infect Dis. 2021;23(4):e13672.
Leeaphorn N, Thongprayoon C, Chon WJ, Cummings LS, Mao MA, Cheungpasitporn W. Outcomes of kidney retransplantation after graft loss as a result of BK virus nephropathy in the era of newer immunosuppressant agents. Am J Transplant. 2020;20(5):1334–40.
Dharnidharka VR, Cherikh WS, Neff R, Cheng Y, Abbott KC. Retransplantation after BK virus nephropathy in prior kidney transplant: an OPTN database analysis. Am J Transplant. 2010;10(5):1312–5.
Bussalino E, Marsano L, Parodi A, et al. Everolimus for BKV nephropathy in kidney transplant recipients: a prospective, controlled study. J Nephrol. 2021;34(2):531–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Sriperumbuduri, S., Syed, B. (2022). Failed Allograft Due to Persistent BKV. In: Aziz, F., Parajuli, S. (eds) Complications in Kidney Transplantation. Springer, Cham. https://doi.org/10.1007/978-3-031-13569-9_66
Download citation
DOI: https://doi.org/10.1007/978-3-031-13569-9_66
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-13568-2
Online ISBN: 978-3-031-13569-9
eBook Packages: MedicineMedicine (R0)